Analyst Ratings for Nektar Therapeutics (nktr)
nktr Rating Summary
nktr Price Target Summary
- Highest: $192.00 (Piper Sandler)
- Lowest: $95.00 (Wedbush)
- Average: $154.89
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$154.89 (+112.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$154.89 (+112.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/22/2026 | Canaccord | Edward Nash | New Coverage | Buy (N/A) |
153.00 (N/A) |
68.67 (73.02) |
6.33% | Details |
| 3/24/2026 | Wedbush » Updated 4/20/2026 |
Martin Fan | New Coverage | Neutral (N/A) |
95.00 (70.00) |
74.34 (73.02) |
-1.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
